You are using an outdated browser. Please upgrade your browser to improve your experience.
Become a Fellow
ACP offers a number of resources to help members make sense of the MOC requirements and earn points.
Understanding MOC Requirements
Earn MOC points
The most comprehensive meeting in Internal Medicine.
April 11-13, 2019
Internal Medicine Meeting 2019
Prepare for the Certification and Maintenance of Certification (MOC)
Exam with an ACP review course.
Board Certification Review Courses
MOC Exam Prep Courses
Treating a patient? Researching a topic? Get answers now.
Visit AnnalsLearn More
Visit MKSAP 17 Learn More
Visit DynaMed Plus
Ensure payment and avoid policy violations. Plus, new resources to help you navigate the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Access helpful forms developed by a variety of sources for patient charts, logs, information sheets, office signs, and use by practice administration.
ACP advocates on behalf on internists and their patients on a number of timely issues. Learn about where ACP stands on the following areas:
© Copyright 2018 American College of Physicians. All Rights Reserved. 190 North Independence Mall West, Philadelphia, PA 19106-1572
Toll Free: (800) 523.1546 · Local: (215) 351.2400
(from the February 2017 ACP Internist)
At some point in their lives, most people who have sex become infected with a genotype of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Before the HPV vaccine became available, the average lifetime probability of acquiring the virus among U.S. men and women with at least one partner of the opposite sex was about 91% and 85%, respectively, CDC researchers estimated in a 2014 article published in Sexually Transmitted Diseases.
Although most people who acquire HPV generally resolve it without health problems, certain persistent types of HPV cause most cervical cancers and many cancers of the genitals, anus, rectum, and oropharynx. HPV vaccination can prevent most of these cancers from ever developing by preventing infections with cancer-causing HPV types, according to the CDC.
While HPV immunization is recommended during adolescence and might seem less useful in older adults, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
In the U.S., three vaccines are licensed to prevent HPV infection: a bivalent vaccine (Cervarix, approved by the FDA in 2009), which protects against types 16 and 18; a quadrivalent vaccine (Gardasil, approved in 2006) against types 6, 11, 16, and 18; and a nine-valent vaccine (Gardasil 9, approved in 2014) against types 6, 11, 16, 18, 31, 33, 45, 52, and 58. As of 2017, only the nine-valent vaccine is distributed in the U.S., according to the CDC.
Read the full article in ACP Internist.
ACP Internist provides news and information for internists about the practice of medicine and reports on the policies, products, and activities of ACP.
Back to March 2017 Issue of IMpact